Navigation Links
Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants

- Results Presented at 160th Annual Meeting of the American Psychiatric Association -

SAN DIEGO, May 21, 2007 /PRNewswire-FirstCall/ -- In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery- Asberg Depression Rating Scale (MADRS) Total Score. In this six-week, randomized, placebo-controlled study presented here at the 160th Annual Meeting of the American Psychiatric Association, the Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. atypical antipsychotic aripiprazole was added to antidepressants in patients who did not have an adequate response to ADT alone.(1) These findings are from one of two completed studies evaluating adjunctive aripiprazole with ADT.

"Investigational studies are important because many patients with major depressive disorder do not achieve adequate symptom response," said study investigator Arif Khan, M.D., Medical Director, Northwest Clinical Research Center, Bellevue, Wash., and Adjunct Professor, Psychiatry, Duke University, Durham, N.C. "The findings from this study contribute more information about the potential use of add-on medications to antidepressant therapy in patients who inadequately respond to antidepressants alone."

Study Design and Findings

This double-blind, randomized, placebo-controlled, multi-center, six-week study enrolled adults diagnosed with major depressive disorder who had an inadequate response to one or more ADTs. After a seven to 28-day screening phase, adults in this study underwent an eight-week prospective treatment phase with one ADT plus single-blind placebo to confirm their inadequate response to ADT. The ADTs included escitalopram, fluoxetine, paroxetine controlled release, sertraline or venlafaxine extended release, dosed per label guidelines. A total of 362 adults with inadequate response then entered
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:12/24/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), ... the development of brachytherapy devices and medical isotopes ... it has filed a de novo ... for marketing clearance for its patented Y-90 RadioGel(TM) ... Food, Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... , Dec. 23, 2014  The American Diabetes ... pressure target for people with diabetes and that ... high doses of statins, in keeping with recent ... by the American College of Cardiology (ACC) and ... in the most recent changes to the Association,s ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... , May 13 Pacific Bridge Medical, a leading Asia ... on May 26, 2010 at 11am EDT . , ... Taiwan is the sixth largest pharmaceutical market in the ... a solid national health care system. This webcast will give an overview of ...
... , SEATTLE , May 13 ... company, today announced that, based on successful preclinical studies, ... MASP-2 antibody program and has initiated the cGMP manufacturing ... have shown that Omeros, proprietary, fully human, monoclonal MASP-2 ...
Cached Medicine Technology:Pacific Bridge Medical to Host Taiwan Drug Registration Webinar 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 3Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 4
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Adults who experienced ... of migraine headaches, suggests a study published online ... "Childhood maltreatment can have long-lasting effects, like ... adulthood," study author Dawn Buse, director of behavioral ... City, said in a journal news release. ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... start smoking or drinking with each additional symptom they ... new research suggests. "Our findings underscore the ... use as [these] children approach adolescence," said study author ... Group, which is part of Cincinnati Children,s Hospital. "This ...
(Date:12/24/2014)... Reinberg HealthDay Reporter TUESDAY, ... American Diabetes Association (ADA) call for giving the cholesterol-lowering drugs ... prevent heart disease. These new standards bring the association ... Heart Association, which also recommend giving low- or high-dose statins ... with diabetes. "We agree that the decision to start ...
(Date:12/24/2014)... For chic ladies, new fashionable outfits are necessary when ... Holiday Wish List, Angeldress.co.uk has chosen some of ... ladies’ holiday wardrobe by launching a promotion on its cheap ... discount of 80% off, like a cheap suit. , “All ... chic wedding dresses are among the hottest items in the ...
(Date:12/24/2014)... December 24, 2014 Dr. Svetlana Gomer, ... across the nation gathered with US Marines on November ... raise funds for the Toys for Tots Literacy Program. ... thousands of new books and audio books for the ... underprivileged children this Christmas. It represents another major strike ...
Breaking Medicine News(10 mins):Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3
... and MDS Pharma Services, Goodwill, , ... (TSX: MDS; NYSE: MDZ ), a leading provider of ... update for fiscal 2008 performance. , Based on preliminary ... the range of $1,210 million to $1,220 million and adjusted EBITDA ...
... Congress are determined to complete the job started around 1900 and ... They plan to move fast, seize momentum, and not let go. ... on the offense," said former South Dakota Senator Tom Daschle, presumptive ... , The bill might well be S. 1, and ...
... plc (NASDAQ:, ICLR )(ISIN:IE0005711209), a global ... biotechnology and medical device industries,today announced that ... new cardiac,echocardiography analysis software solution. The software, ... viewed, measured and interpreted,in clinical trials and ...
... spending hundreds of millions annually to prevent dry skin... much of the ... can be taken to heal and protect the skin. , ... Denver, ... of the year for scores of people across the country suffering from ...
... out of Wake Forest University School of Medicine and the ... popular class of oral diabetic drugs doubles the risk of ... findings appear online today on the Web site for the ... the January 6 issue. , "We knew going into this ...
... highlights from the December issue of Mayo Clinic Women,s HealthSource ... Mayo Clinic Women,s HealthSource attribution is ... subscription information as your editorial policies permit: Visit www.bookstore.mayoclinic.com ... , , Who,s ...
Cached Medicine News:Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Blitzkrieg Declared On American Medicine 2Health News:Blitzkrieg Declared On American Medicine 3Health News:ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 3Health News:Popular class of diabetes drugs doubles risk of fractures in women 2Health News:Popular class of diabetes drugs doubles risk of fractures in women 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 2Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 4Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 5
... The SkanWasher 400 is ... microplate washer with built-in ... The individual pressure settings ... very gentle wash to ...
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
... a compact and versatile multilabel ... design allows up to six ... counting, luminescence, absorbance, and fluorescence ... and fluorescence polarization all on ...
Medicine Products: